Simultaneous determination of kynurenine and kynurenic acid in human urine by HPLC with ultraviolet and fluorescence detector

ZHAO Jianxing,LUO Xuemei,ZHAN Yiming,CHEN Bo,ZHU Dingliang

IF: 1.865

2009-01-01

Laboratory Medicine

Abstract:Objective To establish the high performance liquid chromatography (HPLC) method for determining kynurenine (KYN) and kynurenic acid (KYNA) in human urine simultaneously. To evaluate the activity of human kynurenic aminotransferase (KAT) with KYNA/KYN ratio. Methods The levels of KYN and KYNA were determined by HPLC. Analytical column: Agilent HC C18 column. Mobile phase: a buffer solution of 10 mmol/L sodium acetate-acetic acid ∶7% acetonitrile=93 ∶7. Flow rate: 1 mL/min. Wavelengths of detectors: ultraviolet,365 nm;fluorescence,excitation 344 nm/emission 398 nm. Results The retention times of KYN and KYNA were 6.9 and 11.5 min respectively. There was not significant difference between the slopes of linear regression curves of aqueous and urine-matched standard-addition curves (KYN: P=0.406 8;KYNA: P=0.646 2). The average recoveries of KYN and KYNA were 98.74%±7.53% and 95.17%±8.17%. The coefficients of variation (CV) of KYN and KYNA were 3.35 % and 0.88 % for stability test,2.73 % and 2.79 % for precision test. The lowest detection limit of the method was 0.4 μmol/L for KYN and 0.2 μmol/L for KYNA. The KYNA/KYN ratio of 30 urine samples of healthy subjects was 2.45±1.54. There was positive correlation between KYNA and KYN levels in urine (r2=0.375 8,P<0.001). Conclusions The method is sensitive,accurate and stable. Using KYNA/KYN ratio to determine the activity of KAT has the characteristics of convenience and practicability and this method could be used for the clinical diagnosis and fundamental research for some relative diseases.